Skip Navigation


Rheumatology Advance Access originally published online on January 19, 2009
Rheumatology 2009 48(3):285-288; doi:10.1093/rheumatology/ken486
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/3/285    most recent
ken486v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Foster, W.
Right arrow Articles by Blann, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foster, W.
Right arrow Articles by Blann, A. D.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction

Will Foster1, Eduard Shantsila1, David Carruthers2, Gregory Y. H. Lip1 and Andrew D. Blann1

1University Department of Medicine and 2Department of Rheumatology, City Hospital, Birmingham, UK.

Correspondence to: Andrew D. Blann, University Department of Medicine, City Hospital, Birmingham, B18 7QH, UK. E-mail: a.blann{at}bham.ac.uk


  Abstract

Objectives. RA is associated with endothelial cell dysfunction (ECD) and increased cardiovascular mortality and morbidity. Circulating endothelial cells (CECs) are a novel marker of severe endothelial damage. We hypothesized altered CECs in patients with RA compared with community controls (CCs) and hospital controls (HCs, with diabetes and hypertension) correlate with established plasma markers of inflammation and of ECD.

Methods. CECs (CD146-immunobeads), von Willebrand factor, soluble E-selectin, soluble intercellular adhesion molecule-1, soluble vascular endothelial adhesion molecule-1 (sVCAM, all ELISA) and C-reactive protein (CRP, immunonephelometry) were measured in 57 patients with RA, 45 CC and 23 HC patients.

Results. CECs in RA [median/interquartile range 8 (5–13.5) cells/ml] were elevated compared with either CC [4 (2–8.5) cells/ml] or HC [4 (1–8) cells/ml] (both P < 0.001). Levels of CECs did not correlate with other markers of ECD or of inflammation but did correlate inversely with sVCAM.

Conclusion. Evidence of endothelial damage in the form of mildly increased numbers of CECs is present in RA and is independent of plasma markers of inflammation and of ECD.

KEY WORDS: Rheumatoid arthritis, von Willebrand factor, C-reactive protein, Circulating endothelial cells, Soluble E selectin

Submitted 10 July 2008; revised version accepted 1 December 2008.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.